Building long-term partnerships around data and science.
We collaborate with organizations across the life sciences ecosystem to accelerate research, enhance clinical development, and strengthen drug safety operations.
DG BioTech LLC collaborates with organizations across the life sciences ecosystem to accelerate research, enhance clinical development, and strengthen drug safety operations. Our partners include biopharmaceutical companies, biotechnology startups, academic research institutions, contract research organizations (CROs), and healthcare data providers.
We work closely with partners to co-develop analytical workflows, support complex research programs, and provide strategic insights that guide decision-making from discovery through post-market surveillance. Our collaborative model emphasizes transparency, scientific rigor, and shared innovation—allowing our partners to leverage advanced computational tools and high-quality analytics without the overhead of building internal infrastructure.
Strategic partnerships
Bringing together expertise, data, and technology to accelerate therapeutic discovery, enhance clinical development, and improve drug safety outcomes.
Collaborative innovation
Co-developed analytical workflows, predictive models, and data platforms that strengthen research pipelines and support evidence-based decision-making.
Flexible, scalable engagement
Project-based support, ongoing analytics services, and integrated R&D collaborations tailored to partner needs and growth.
Scientific & regulatory alignment
Partnerships built on scientific rigor, transparency, and compliance with regulatory standards across discovery, development, and safety.
Who we partner with
- Biopharmaceutical & biotechnology companies.
- Academic and research institutions.
- Contract research organizations (CROs).
- Technology and data providers.
Areas of collaboration
- Genomic analytics and multi-omic integration.
- AI-driven drug discovery and target identification.
- Clinical trial design, modeling, and optimization.
- Real-world evidence and safety signal detection.
- Post-market safety analysis and pharmacovigilance analytics.
Partner with us
We welcome collaboration with organizations seeking to advance scientific discovery, streamline development timelines, and bring safer, more effective therapies to patients faster.